EpCAM aptamer-functionalized polydopamine-coated mesoporous silica nanoparticles loaded with DM1 for targeted therapy in colorectal cancer.

about

EpCAM aptamer-functionalized polydopamine-coated mesoporous silica nanoparticles loaded with DM1 for targeted therapy in colorectal cancer.

Item

http://www.wikidata.org/entity/Q46873437

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

EpCAM aptamer-functionalized p ...... therapy in colorectal cancer.

@en

EpCAM aptamer-functionalized p ...... therapy in colorectal cancer.

@nl

type

Item

label

EpCAM aptamer-functionalized p ...... therapy in colorectal cancer.

@en

EpCAM aptamer-functionalized p ...... therapy in colorectal cancer.

@nl

prefLabel

EpCAM aptamer-functionalized p ...... therapy in colorectal cancer.

@en

EpCAM aptamer-functionalized p ...... therapy in colorectal cancer.

@nl

P1476

EpCAM aptamer-functionalized p ...... therapy in colorectal cancer.

@en

P2093

Han Zhang

http://www.w3.org/2001/XMLSchema#string

Hao Huang

http://www.w3.org/2001/XMLSchema#string

Jinfeng Luo

http://www.w3.org/2001/XMLSchema#string

Kai Ling

http://www.w3.org/2001/XMLSchema#string

Lisheng He

http://www.w3.org/2001/XMLSchema#string

Shiyun Bao

http://www.w3.org/2001/XMLSchema#string

Xiaofang Yu

http://www.w3.org/2001/XMLSchema#string

Yang Li

http://www.w3.org/2001/XMLSchema#string

Yanhong Duo

http://www.w3.org/2001/XMLSchema#string

Yue Zhang

http://www.w3.org/2001/XMLSchema#string

P2860

Mussel-inspired surface chemistry for multifunctional coatings

Global cancer statistics, 2012

Frequent EpCam protein expression in human carcinomas

High-affinity accumulation of a maytansinoid in cells via weak tubulin interaction.

Diagnosis of prostate cancer using anti-PSMA aptamer A10-3.2-oriented lipid nanobubbles

Theranostic mesoporous silica nanoparticles biodegrade after pro-survival drug delivery and ultrasound/magnetic resonance imaging of stem cells.

Phase II study of the antibody drug conjugate trastuzumab-DM1 for the treatment of human epidermal growth factor receptor 2 (HER2)-positive breast cancer after prior HER2-directed therapy.

FDA approval: ado-trastuzumab emtansine for the treatment of patients with HER2-positive metastatic breast cancer.

Aptamer-conjugated PEGylated quantum dots targeting epidermal growth factor receptor variant III for fluorescence imaging of glioma

Cancer nanotechnology: the impact of passive and active targeting in the era of modern cancer biology.

P304

6239-6257

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-08-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P921

colorectal cancer

P932

5584901

http://www.w3.org/2001/XMLSchema#string